RMR Wealth Builders’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
RMR Wealth Builders's PFE Position: Q4 2023 in Review
RMR Wealth Builders sold out of Pfizer (PFE) in Q4 2023, closing a stake of 9,897 shares — an estimated $328K sold.
RMR Wealth Builders first reported a position in PFE in Q4 2019 and held it in 15 quarters. The position peaked at $735K in Q3 2020. 2,940 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- RMR Wealth Builders reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
- RMR Wealth Builders sold 9,897 Pfizer shares in Q4 2023, an estimated $328K.
- RMR Wealth Builders first reported a position in Pfizer in Q4 2019 and held it in 15 quarters.
- RMR Wealth Builders's Pfizer position peaked at $735K in Q3 2020.
- 2,940 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on RMR Wealth Builders's 13F filing for Q4 2023, filed 6 Feb 2024.